Relief Therapeutics Holding SA logo

Relief Therapeutics Holding SA

LTS:0QKQ (Switzerland)  
CHF 62.96 (0%) Apr 23
At Loss
P/B:
0.17
Market Cap:
CHF 15.70M ($ 17.16M)
Enterprise V:
CHF 6.15M ($ 6.72M)
Volume:
-
Avg Vol (2M):
-
Also Trade In:

Business Description

Description
Relief Therapeutics Holding SA is engaged in the research, development, and commercialization of biopharmaceutical products. It mainly develops drugs of natural human origin. It has a focus on commercial products and the development program pipeline is focused on three main areas: rare genetic, metabolic disorders, rare connective tissue disorders, and rare lung diseases. Geographically group generates the majority of its revenue from Europe.
Name Current Vs Industry Vs History
Cash-To-Debt 3.95
Equity-to-Asset 0.75
Debt-to-Equity 0.03
Debt-to-EBITDA -0.04
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -1.5
Distress
Grey
Safe
Beneish M-Score -1.22
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.3
Quick Ratio 2.23
Cash Ratio 1.8
Days Inventory 8.14
Days Sales Outstanding 70.4
Days Payable 47.34

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -27.7
Shareholder Yield % -45.99
Name Current Vs Industry Vs History
Gross Margin % -134.61
Operating Margin % -478.44
Net Margin % -1378.18
FCF Margin % -351.74
ROE % -60.41
ROA % -45.18
ROIC % -15.63
ROC (Joel Greenblatt) % -3262.7
ROCE % -53.82

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 2.44
PB Ratio 0.17
EV-to-EBIT -0.06
EV-to-EBITDA -0.06
EV-to-Revenue 1.05
EV-to-FCF -0.31
Earnings Yield (Greenblatt) % -1499.44
FCF Yield % -131.32

Financials (Next Earnings Date:2024-09-13 Est.)

LTS:0QKQ's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Relief Therapeutics Holding SA Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil CHF) 5.862
EPS (TTM) (CHF) -7.347
Beta -0.43
Volatility % 0
14-Day RSI 0
14-Day ATR (CHF) 0
20-Day SMA (CHF) 62.96
12-1 Month Momentum % 0
52-Week Range (CHF) 62.96 - 62.96
Shares Outstanding (Mil) 12.22

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Relief Therapeutics Holding SA Filings

Filing Date Document Date Form
No Filing Data

Relief Therapeutics Holding SA Stock Events

Financials Calendars
Event Date Price(CHF)
No Event Data

Relief Therapeutics Holding SA Frequently Asked Questions

What is Relief Therapeutics Holding SA(LTS:0QKQ)'s stock price today?
The current price of LTS:0QKQ is CHF62.96. The 52 week high of LTS:0QKQ is CHF62.96 and 52 week low is CHF62.96.
When is next earnings date of Relief Therapeutics Holding SA(LTS:0QKQ)?
The next earnings date of Relief Therapeutics Holding SA(LTS:0QKQ) is 2024-09-13 Est..
Does Relief Therapeutics Holding SA(LTS:0QKQ) pay dividends? If so, how much?
Relief Therapeutics Holding SA(LTS:0QKQ) does not pay dividend.

Press Release

Subject Date
No Press Release